Cat:GMP-MPV-Tg04-nAb
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Description
Cat No.
GMP-MPV-Tg04-nAb001
Target
A25
Product Name (Neutralizing antibody Name)
Anti-MPV (A25) human monoclonal neutralizing antibody (IgG1)
Source (Expression Host)
Mammalian (human cell)
Isotypes
human IgG1
Bioactivity validation
Validated in Monkeypox virus (MPV) A25 antigen protein binding affnity.ELISA validated as capture antibody and detection antibody. Pair recommendation with other A25 antibodies in A25 level test of Monkeypox virus (MPV) infectious diseases.
Tag
hFc
Products description
Anti-MPV (A25) human monoclonal neutralizing antibody (IgG1) is a potency validated Monkeypox virus (MPV) neutralizing antibody. It is a human IgG1 antibody produced by Mammalian (human cell). The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other A25 antibodies.
Reconized/Reactive Species
Human
Purity
Purity: ≥95% (SDS-PAGE)
Application
This antibodies can either act as positive control in Monkeypox virus (MPV) related vaccines and neutralizing antibodies discovery and development, or act as a benchmark in Monkeypox virus (MPV) neutralization potency assay. ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation
Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage
Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
